Endocyte, Inc. to Present at the 18th Annual BioCentury NewsMakers Conference
WEST LAFAYETTE, Ind., Oct. 14, 2011 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that Mike Sherman, chief financial officer of Endocyte, will present at the upcoming 18th Annual Newsmakers in the Biotech Industry Conference on Friday, Oct. 21, 2011 at 2:30 p.m. EDT. The conference will be held at the Millennium Broadway Hotel in New York.
A live audio webcast of the Company's presentation can be accessed at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=ECYT&item_id=4210402 or under "Events & Presentations" in the Investor Relations section of Endocyte's website at www.endocyte.com. The webcast will be archived shortly after the live event and a replay will be available on the Company's website for 90 days following
Endocyte is a biopharmaceutical company developing targeted therapies for the treatment of cancer and inflammatory diseases. Endocyte uses its proprietary technology to create novel SMDCs and companion imaging diagnostics for personalized targeted therapies. The company's SMDCs actively target receptors that are over-expressed on diseased cells, relative to healthy cells. This targeted approach is designed to enable the treatment of patients with highly active drugs at greater doses, delivered more frequently, and over longer periods of time than would be possible with the untargeted drug alone. The companion imaging diagnostics are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment.
CONTACT: Stephanie Ascher, Stern Investor Relations, Inc.,
(212) 362-1200, email@example.com
Martina Schwarzkopf, Ph.D., Russo Partners,
(212) 845-4292, firstname.lastname@example.org
Tony Russo, Ph.D., Russo Partners,
(212) 845-4251, email@example.com
Source: Endocyte, Inc.
News Provided by Acquire Media
Close window | Back to top